The DOI matches its Crossref record.
Protective efficacy of recombinant exotoxin A — flagellin fusion protein against Pseudomonas aeruginosa infection
Abstract
Pseudomonas aeruginosa is an opportunistic bacterium that causes serious nosocomial infection in immunocompromised patients. The aim of this study was to prepare a fusion protein consisting of exotoxin A (ExoA) and flagellin (Fla) from P. aeruginosa and to evaluate its potential as a vaccine candidate against P. aeruginosa infection. The genes encoding for ExoA and Fla proteins were cloned in-frame and expressed in Escherichia coli. The recombinant ExoA–Fla fusion protein was purified by Ni-NTA affinity chromatography. Mice were immunized subcutaneously with ExoA, Fla, and ExoA–Fla fusion proteins, and the humoral immune response was evaluated by ELISA method. The immunized and control group mice were challenged with a 2× LD 50 (7.5 × 10 7 CFU) of P. aeruginosa for the protection assay. The results indicated that vaccination with Fla, ExoA, and ExoA–Fla fusion proteins produced a significant amount of specific immunoglobulin G antibodies. Immunization of mice with ExoA–Fla fusion protein showed significant protection against intraperitoneal challenge with 7.5 × 10 7 CFU (2× LD 50) P. aeruginosa. Results of this study suggest that recombinant ExoA–Fla fusion protein is a highly immunogenic protective protein showing promise as a vaccine candidate against P. aeruginosa.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other strategies, such as monoclonal antibodies, have been developed to neutralize bacterial toxins such as exotoxin A117.”
From Pseudomonas aeruginosa: ecology, evolution, pathogenesis and antimicrobial susceptibility (2025) · cites this paper as [117]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 24
- 10.1016/j.burns.2008.08.014 · doi:10.1016/j.burns.2008.08.014
- 10.1128/IAI.00806-09 · DOI
- 10.1007/s002530051555 · doi:10.1007/s002530051555
- 10.1093/clinids/9.Supplement_5.S644 · doi:10.1093/clinids/9.supplement_5.s644
- Cryz S.J., 1991, Infect. Immun., 59, 45, 10.1128/iai.59.1.45-50.1991 · doi:10.1128/iai.59.1.45-50.1991
- 10.1111/j.1574-695X.2000.tb01425.x · doi:10.1111/j.1574-695x.2000.tb01425.x
- 10.1016/j.vaccine.2007.12.007 · doi:10.1016/j.vaccine.2007.12.007
- 10.1073/pnas.0702403104 · DOI · Paper page
- 10.4061/2011/970983 · doi:10.4061/2011/970983
- 10.1007/s10529-009-0026-1 · DOI
- 10.1038/nprot.2007.132 · DOI · Paper page
- 10.1128/IAI.69.11.6962-6969.2001 · doi:10.1128/iai.69.11.6962-6969.2001
- 10.1128/IAI.01139-10 · DOI
- 10.1099/jmm.0.46696-0 · doi:10.1099/jmm.0.46696-0
- 10.1186/1471-2180-9-23 · doi:10.1186/1471-2180-9-23
- Matsumoto T., 1999, Clin. Diagn. Lab. Immunol., 6, 537, 10.1128/CDLI.6.4.537-541.1999 · doi:10.1128/cdli.6.4.537-541.1999
- 10.3892/ijmm.16.1.165 · doi:10.3892/ijmm.16.1.165
- 10.1016/j.jchromb.2007.05.029 · DOI
- Reed L., 1938, Am. J. Epidemiol., 27, 493, 10.1093/oxfordjournals.aje.a118408 · DOI · Paper page
- 10.1016/S0264-410X(00)00335-2 · DOI
- Tanomand A., 2012, Iran. Biomed. J., 17, 1
- Tavajjohi Z., 2011, Iran. J. Clin. Infect. Dis., 6, 18
- 10.1128/IAI.00054-09 · DOI
- 10.1016/j.ijmm.2008.08.003 · DOI · Paper page
Cited by
Pseudomonas Exotoxin A: optimized by evolution for effective killing
Michalska, M., & Wolf, P. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00963 · Cited by 283
Pseudomonas aeruginosa: ecology, evolution, pathogenesis and antimicrobial susceptibility
Letizia, M., Diggle, S. P., & Whiteley, M. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01193-8 · Cited by 231
Metadata
- Authors
- Farajnia, S., Peerayeh, S. N., Tanomand, A., Majidi, J., Goudarzi, G., Naghili, B., & Rahbarnia, L.
- Venue
- Canadian Journal of Microbiology
- Publisher
- Canadian Science Publishing
- Published
- 2015-01
- Volume
- 61
- Issue
- 1
- Pages
- 60-64
- ISSN
- 0008-4166
- 1480-3275
- Cited by
- 14
- References
- 0
- Language
- en
- Licence
- www.nrcresearchpress.com/page/about/CorporateTextAndDataMining (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Protective efficacy of recombinant exotoxin A — flagellin fusion protein against Pseudomonas aeruginosa infection. https://app.cochat.ai/papers/10.1139/cjm-2014-0501
- The paper
- Farajnia, S., Peerayeh, S. N., Tanomand, A., Majidi, J., Goudarzi, G., Naghili, B., & Rahbarnia, L. (2015). Protective efficacy of recombinant exotoxin A — flagellin fusion protein against Pseudomonas aeruginosa infection. Canadian Journal of Microbiology. https://doi.org/10.1139/cjm-2014-0501
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.